Combined 21-hydroxylase deficiency and 17α-hydroxylase/17,20-lyase deficiency :an undervirilized male.

CYP17A1 CYP21A2 Congenital Adrenal Hyperplasia gynecomastia hearing loss

Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
07 Jun 2024
Historique:
received: 30 01 2023
revised: 23 05 2024
accepted: 05 06 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 9 6 2024
Statut: aheadofprint

Résumé

21-hydroxylase deficiency stands as the most prevalent form of congenital adrenal hyperplasia, primarily resulting from mutations in the CYP21A2 gene. On the other hand, mutations within the CYP17A1 gene lead to 17α-hydroxylase/17,20-lyase enzyme deficiencies. The scarcity of 17-OH deficiency is noteworthy, accounting for less than 1% of all congenital adrenal hyperplasia cases. The male patient, born from a first-degree cousin marriage, exhibited several symptoms, including left undescended testis, micropenis, penile chord, left sensorineural hearing loss, and gynecomastia. He reported micropenis as a concern at the age of 13.5 years. His hormone profile revealed high levels of serum 17-hydroxyprogesterone, progesterone, and pregnenolone. In this case with a 46 XY karyotype, suspicions arose regarding Cytochrome P450 oxidoreductase deficiency due to ambiguous genitalia and an atypical hormone profile. Analysis unveiled two distinct homozygous and pathogenic variants in the CYP21A2 and CYP17A1 genes. Notably, mineralocorticoid precursors escalated, while cortisol and sex steroid precursors decreased during the high (250 mcg) dose ACTH stimulation test. The mutation c.1169C>G (p.Thr390Arg) in CYP17A1, which is the second documented case in literature, stands out due to its unique set of accompanying features. Mutations occurring in CYP21A2 and CYP17A1 result in complete or partial enzyme deficiencies, and the detection of homozygous mutations in two different enzyme systems within the steroidogenic pathway is noteworthy.

Identifiants

pubmed: 38852772
pii: S1769-7212(24)00044-2
doi: 10.1016/j.ejmg.2024.104952
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104952

Informations de copyright

Copyright © 2024. Published by Elsevier Masson SAS.

Auteurs

Leyla Kara (L)

Erciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri. Electronic address: leyladumann@gmail.com.

Dilek Cicek (D)

Erciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri. Electronic address: cicekdilek87@hotmail.com.

Ulku Gul Siraz (UG)

Erciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri. Electronic address: dr.ulku.81@hotmail.com.

Murat Erdogan (M)

Kayseri City Hospital Department of Medical Genetics Leyla Kara. Electronic address: drmerdogan40@gmail.com.

Emre Sarikaya (E)

Erciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri. Electronic address: sarikaya.emre@gmail.com.

Ebru Gok (E)

Erciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri. Electronic address: sumanebru@hotmail.com.

Ugur Berber (U)

Erciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri. Electronic address: drugurberber@gmail.com.

Selim Kurtoglu (S)

Erciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri. Electronic address: selimchief@gmail.com.

Mustafa Kendirci (M)

Erciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri. Electronic address: kendirci@erciyes.edu.tr.

Nihal Hatipoglu (N)

Erciyes University Faculty of Medicine, Department of Pediatric Endocrinology, Kayseri. Electronic address: nihalhatipoglu@yahoo.com.

Classifications MeSH